Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes

1218.17.10003 Boehringer Ingelheim Investigational Site, Chula Vista

1218.17.10014 Boehringer Ingelheim Investigational Site, Spring Valley

1218.17.10001 Boehringer Ingelheim Investigational Site, Walnut Creek

1218.17.10021 Boehringer Ingelheim Investigational Site, Northglenn

1218.17.10010 Boehringer Ingelheim Investigational Site, Hollywood

1218.17.10011 Boehringer Ingelheim Investigational Site, Miami

1218.17.10008 Boehringer Ingelheim Investigational Site, Pembroke Pines

1218.17.10017 Boehringer Ingelheim Investigational Site, Gurnee

1218.17.10006 Boehringer Ingelheim Investigational Site, Omaha

1218.17.10012 Boehringer Ingelheim Investigational Site, Charlotte

1218.17.10013 Boehringer Ingelheim Investigational Site, Mentor

1218.17.10015 Boehringer Ingelheim Investigational Site, Oklahoma City

1218.17.10016 Boehringer Ingelheim Investigational Site, Eugene

1218.17.10002 Boehringer Ingelheim Investigational Site, Greer

1218.17.10004 Boehringer Ingelheim Investigational Site, Simpsonville

1218.17.10005 Boehringer Ingelheim Investigational Site, Dallas

1218.17.10018 Boehringer Ingelheim Investigational Site, Houston

1218.17.10007 Boehringer Ingelheim Investigational Site, San Antonio

1218.17.10009 Boehringer Ingelheim Investigational Site, Federal Way

1218.17.42001 Boehringer Ingelheim Investigational Site, Brno

1218.17.42004 Boehringer Ingelheim Investigational Site, Brno

1218.17.42007 Boehringer Ingelheim Investigational Site, Brno

1218.17.42009 Boehringer Ingelheim Investigational Site, Brno

1218.17.42006 Boehringer Ingelheim Investigational Site, Břeclav

1218.17.42008 Boehringer Ingelheim Investigational Site, Hodonín

1218.17.42003 Boehringer Ingelheim Investigational Site, Olomouc

1218.17.35806 Boehringer Ingelheim Investigational Site, Helsinki

1218.17.35804 Boehringer Ingelheim Investigational Site, Jyväskylä

1218.17.35801 Boehringer Ingelheim Investigational Site, Kuopio

1218.17.35803 Boehringer Ingelheim Investigational Site, Oulu

1218.17.35805 Boehringer Ingelheim Investigational Site, Seinäjoki

1218.17.35802 Boehringer Ingelheim Investigational Site, Turku

1218.17.30004 Boehringer Ingelheim Investigational Site, Athens

1218.17.30013 Boehringer Ingelheim Investigational Site, Athens

1218.17.30011 Boehringer Ingelheim Investigational Site, Piraeus

1218.17.91009 Boehringer Ingelheim Investigational Site, Andhra Pradesh

1218.17.91002 Boehringer Ingelheim Investigational Site, Bangalore

1218.17.91005 Boehringer Ingelheim Investigational Site, Bangalore

1218.17.91012 Boehringer Ingelheim Investigational Site, Chennai

1218.17.91014 Boehringer Ingelheim Investigational Site, Chennai

1218.17.91010 Boehringer Ingelheim Investigational Site, Hyderabad

1218.17.91006 Boehringer Ingelheim Investigational Site, Jaipur

1218.17.91007 Boehringer Ingelheim Investigational Site, Karnataka

1218.17.91008 Boehringer Ingelheim Investigational Site, Mangalore

1218.17.91004 Boehringer Ingelheim Investigational Site, Mumbai

1218.17.91011 Boehringer Ingelheim Investigational Site, Nagpur

1218.17.91003 Boehringer Ingelheim Investigational Site, Nashik

1218.17.91001 Boehringer Ingelheim Investigational Site, Trivandrum

1218.17.91013 Boehringer Ingelheim Investigational Site, Uttar Pradesh

1218.17.97274 Boehringer Ingelheim Investigational Site, Afula

1218.17.97273 Boehringer Ingelheim Investigational Site, Haifa

1218.17.97275 Boehringer Ingelheim Investigational Site, Holon

1218.17.97271 Boehringer Ingelheim Investigational Site, Jerusalem

1218.17.97272 Boehringer Ingelheim Investigational Site, Nahariya

1218.17.97276 Boehringer Ingelheim Investigational Site, Safed

1218.17.97278 Boehringer Ingelheim Investigational Site, Tel Aviv

1218.17.52007 Boehringer Ingelheim Investigational Site, Aguascalientes, Ags.

1218.17.52009 Boehringer Ingelheim Investigational Site, cOL OBREGON,León, Guanajuato

1218.17.52003 Boehringer Ingelheim Investigational Site, Col. Lomas de San Francisco, Monterrey

1218.17.52001 Boehringer Ingelheim Investigational Site, Col. Mitras Centro, Monterrey, N.L.

1218.17.52010 Boehringer Ingelheim Investigational Site, Col.Americana, Guadalajara, Jalisco

1218.17.52008 Boehringer Ingelheim Investigational Site, Colonia Tlalpan, Mexico

1218.17.52006 Boehringer Ingelheim Investigational Site, Faccionamiento Lomas de Campestre,AGUASCAL

1218.17.52005 Boehringer Ingelheim Investigational Site, Lomas de Reforma

1218.17.52002 Boehringer Ingelheim Investigational Site, México

1218.17.52004 Boehringer Ingelheim Investigational Site, Tlalpan-México D,F

1218.17.64004 Boehringer Ingelheim Investigational Site, Christchurch

1218.17.64003 Boehringer Ingelheim Investigational Site, Dunedin

1218.17.64002 Boehringer Ingelheim Investigational Site, Otahuhu

1218.17.64001 Boehringer Ingelheim Investigational Site, Tauranga

1218.17.64005 Boehringer Ingelheim Investigational Site, Wellington

1218.17.70001 Boehringer Ingelheim Investigational Site, Moscow

1218.17.70002 Boehringer Ingelheim Investigational Site, Moscow

1218.17.70003 Boehringer Ingelheim Investigational Site, Moscow

1218.17.70005 Boehringer Ingelheim Investigational Site, Novosibirsk

1218.17.70006 Boehringer Ingelheim Investigational Site, Perm

1218.17.70004 Boehringer Ingelheim Investigational Site, Tomsk

1218.17.46013 Boehringer Ingelheim Investigational Site, Härnösand

1218.17.46001 Boehringer Ingelheim Investigational Site, Malmo

1218.17.46012 Boehringer Ingelheim Investigational Site, Uddevalla

1218.17.46004 Boehringer Ingelheim Investigational Site, Uppsala

1218.17.46015 Boehringer Ingelheim Investigational Site, Uppsala